The Latest: Emergent: FDA lets its vaccine factory restart
|
July 29, 2021 6:30 AM
BALTIMORE, Md. — The U.S. Food and Drug Administration is allowing the troubled factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine bulk substance, the company said Thursday.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
